Bio Essence Corporation
BIOE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $4,181 | $9,502 | $9,160 |
| - Cash | $29 | $0 | $0 | $1 |
| + Debt | $0 | $2,589 | $2,743 | $2,705 |
| Enterprise Value | – | $6,770 | $12,246 | $11,864 |
| Revenue | $137 | $259 | $22 | $148 |
| % Growth | -47.2% | 1,067.8% | -85% | – |
| Gross Profit | $96 | $169 | $21 | $107 |
| % Margin | 70% | 65.1% | 92.8% | 72.4% |
| EBITDA | $14 | $61 | -$205 | -$27 |
| % Margin | 10% | 23.6% | -924.3% | -18.1% |
| Net Income | $13 | $60 | -$206 | -$28 |
| % Margin | 9.5% | 23.1% | -927.3% | -18.7% |
| EPS Diluted | 0 | 0.002 | -0.005 | -0.001 |
| % Growth | -81.3% | 129.6% | -671.4% | – |
| Operating Cash Flow | $187 | $168 | -$26 | $423 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $187 | $168 | -$26 | $423 |